πŸ‡ΊπŸ‡Έ FDA
Patent

US 8647633

Recombinant F1-V plague vaccine

granted A61PA61P31/04A61P37/04

Quick answer

US patent 8647633 (Recombinant F1-V plague vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P31/04, A61P37/04